ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,586.74
0.16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Editas Medicine Inc (EDIT)

  7. Editas Medicine Inc (EDIT) News

Editas Medicine (EDIT)

Editas Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EDIT
DateTimeSourceHeadlineSymbolCompany
31/05/202421:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
31/05/202421:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
31/05/202421:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
22/05/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
10/05/202411:00GlobeNewswire Inc.Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
08/05/202421:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EDITEditas Medicine Inc
08/05/202413:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EDITEditas Medicine Inc
08/05/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
08/05/202412:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
02/05/202412:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
01/05/202413:00GlobeNewswire Inc.Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationNASDAQ:EDITEditas Medicine Inc
22/04/202421:31GlobeNewswire Inc.Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
06/03/202401:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202401:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
04/03/202422:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
28/02/202422:13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:EDITEditas Medicine Inc
28/02/202421:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EDITEditas Medicine Inc
28/02/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
28/02/202412:00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
21/02/202412:00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
14/02/202413:40Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EDITEditas Medicine Inc
31/01/202414:00GlobeNewswire Inc.Editas Medicine to Participate in Upcoming Investor ConferencesNASDAQ:EDITEditas Medicine Inc
08/01/202413:15GlobeNewswire Inc.Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
03/01/202412:00GlobeNewswire Inc.Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
13/12/202317:48Dow Jones NewsEditas Medicine Strikes License Deal With Vertex Pharmaceuticals -- UpdateNASDAQ:EDITEditas Medicine Inc
13/12/202314:49Dow Jones NewsEditas Medicine Strikes License Deal With Vertex PharmaceuticalsNASDAQ:EDITEditas Medicine Inc
13/12/202314:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
13/12/202314:00GlobeNewswire Inc.Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9NASDAQ:EDITEditas Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:EDIT

Your Recent History

NASDAQ
TENKR
TenX Keane Acquisition
BIT
F16279
Vontobel Financial Produ...
LSE
FB50
Hsbc Bk.25
EU
C185S
C185S
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved